Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 400 for multiple

Edit search filters
  1. A Study of the Effectiveness and Safety of Ofatumumab Compared to Teriflunomide for the Treatment of Patients with Relapsing Multiple Sclerosis

    Scottsdale/Phoenix, AZ

  2. A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  3. A Study to Assess the Effectiveness, Safety and Tolerability of Lu AF82422 in Patients with Multiple System Atrophy

    Rochester, MN

  4. A Study of BHV-3241 in Subjects with Multiple System Atrophy

    Jacksonville, FL

  5. A Study of Rifampicin in Multiple System Atrophy

    Rochester, MN, Jacksonville, FL

  6. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    Rochester, MN

  7. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

    Rochester, MN

  9. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. A Study for Long-Term Follow-up of Patients with Multiple Sclerosis who Participated in Previous Study of Alemtuzumab

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer